EPFL's cancer drug developer Cellestia Biotech has extended its funding haul to $48.6m in a series B round that featured existing investor PPF Group.

A2A has formed a corporate venturing vehicle with $78m in funding, including a commitment from Polytechnic University of Milan’s Poli360 fund.

MIT-founded genomic data analytics spinout BC Platforms raised the cash in a series C round led by newly minted strategic partner Iqvia.

A2A has formed a corporate venturing arm with $78m in funding, including a commitment from Polytechnic University of Milan’s university venture fund Poli360.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Automotive parts producer Brose will open a corporate venturing office in Berlin as part of a larger investment scheme projected to be up to $2.2bn in size.

The digital health engagement platform, which counts Samsung and Rakuten as existing investors, has completed a series C round of undisclosed size.

Inserm Transfert Initiative was among the investors in a $12.3m funding round for Aelis Farma, which is working on a new class of drugs for cognitive disorders.

Konrad Agustin and Ines Bergmann-Nolting are set to take control of Eon's corporate VC activities following the promotion of Philipp Ulbrich.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.